These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 21144444)

  • 1. The current state of introduction of human papillomavirus vaccination into national immunisation schedules in Europe: first results of the VENICE2 2010 survey.
    Dorleans F; Giambi C; Dematte L; Cotter S; Stefanoff P; Mereckiene J; O'Flanagan D; Lopalco PL; D'Ancona F; Levy-Bruhl D;
    Euro Surveill; 2010 Nov; 15(47):. PubMed ID: 21144444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Introduction of human papillomavirus (HPV) vaccination into national immunisation schedules in Europe: Results of the VENICE 2007 survey.
    King LA; Lévy-Bruhl D; O'Flanagan D; Bacci S; Lopalco PL; Kudjawu Y; Salmaso S;
    Euro Surveill; 2008 Aug; 13(33):. PubMed ID: 18761891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The current state of introduction of HPV vaccination into national immunisation schedules in Europe: results of the VENICE 2008 survey.
    Lévy-Bruhl D; Bousquet V; King LA; O'Flanagan D; Bacci S; Lopalco PL; Salmaso S;
    Eur J Cancer; 2009 Oct; 45(15):2709-13. PubMed ID: 19695863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The current status of HPV and rotavirus vaccines in national immunisation schedules in the EU--preliminary results of a VENICE survey.
    Kudjawu Y; Lévy-Bruhl D; Celentano LP; O'Flanagan D; Salmaso S; Lopalco P; Mullins N; Bacci S;
    Euro Surveill; 2007 Apr; 12(4):E070426.1. PubMed ID: 17868608
    [No Abstract]   [Full Text] [Related]  

  • 5. Organization and quality of HPV vaccination programs in Europe.
    Elfström KM; Dillner J; Arnheim-Dahlström L
    Vaccine; 2015 Mar; 33(14):1673-81. PubMed ID: 25720792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus vaccine introduction--the first five years.
    Markowitz LE; Tsu V; Deeks SL; Cubie H; Wang SA; Vicari AS; Brotherton JM
    Vaccine; 2012 Nov; 30 Suppl 5():F139-48. PubMed ID: 23199957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A brief history of economic evaluation for human papillomavirus vaccination policy.
    Beutels P; Jit M
    Sex Health; 2010 Sep; 7(3):352-8. PubMed ID: 20719227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coverage of the English national human papillomavirus (HPV) immunisation programme among 12 to 17 year-old females by area-level deprivation score, England, 2008 to 2011.
    Hughes A; Mesher D; White J; Soldan K
    Euro Surveill; 2014 Jan; 19(2):. PubMed ID: 24457007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of human papilloma virus (HPV) vaccination strategies and vaccination coverage in adolescent girls worldwide.
    Owsianka B; Gańczak M
    Przegl Epidemiol; 2015; 69(1):53-8, 151-5. PubMed ID: 25862448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Review of the 2016 Swiss immunization schedule and technology update for improving vaccine management].
    Diana A
    Rev Med Suisse; 2016 May; 12(518):949-53. PubMed ID: 27352591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus vaccine effectiveness by number of doses: Systematic review of data from national immunization programs.
    Markowitz LE; Drolet M; Perez N; Jit M; Brisson M
    Vaccine; 2018 Aug; 36(32 Pt A):4806-4815. PubMed ID: 29802000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Country recommendations on the inclusion of HPV vaccines in national immunization programmes among high-income countries, June 2006-January 2008.
    Koulova A; Tsui J; Irwin K; Van Damme P; Biellik R; Aguado MT
    Vaccine; 2008 Dec; 26(51):6529-41. PubMed ID: 18805453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction of human papillomavirus (HPV) vaccination in Belgium, 2007-2008.
    Simoens C; Sabbe M; Van Damme P; Beutels P; Arbyn M
    Euro Surveill; 2009 Nov; 14(46):. PubMed ID: 19941796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inconclusive evidence for non-inferior immunogenicity of two- compared with three-dose HPV immunization schedules in preadolescent girls: A systematic review and meta-analysis.
    Donken R; Knol MJ; Bogaards JA; van der Klis FR; Meijer CJ; de Melker HE
    J Infect; 2015 Jul; 71(1):61-73. PubMed ID: 25709084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current issues facing the introduction of human papillomavirus vaccine in China and future prospects.
    Wong LP; Han L; Li H; Zhao J; Zhao Q; Zimet GD
    Hum Vaccin Immunother; 2019; 15(7-8):1533-1540. PubMed ID: 31017500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Australia leads way on HPV vaccination in boys.
    Wilkinson E
    Lancet Infect Dis; 2012 Nov; 12(11):831-2. PubMed ID: 23256210
    [No Abstract]   [Full Text] [Related]  

  • 17. Vaccine programme stakeholder perspectives on a hypothetical single-dose human papillomavirus (HPV) vaccine schedule in low and middle-income countries.
    Gallagher KE; Kelly H; Cocks N; Dixon S; Mounier-Jack S; Howard N; Watson-Jones D
    Papillomavirus Res; 2018 Dec; 6():33-40. PubMed ID: 30352297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coverage of human papillomavirus vaccination during the first year of its introduction in Spain.
    Limia A; Pachón I
    Euro Surveill; 2011 May; 16(21):. PubMed ID: 21632017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Status of HPV vaccine introduction and barriers to country uptake.
    Gallagher KE; LaMontagne DS; Watson-Jones D
    Vaccine; 2018 Aug; 36(32 Pt A):4761-4767. PubMed ID: 29580641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress toward implementation of human papillomavirus vaccination--the Americas, 2006-2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Oct; 60(40):1382-4. PubMed ID: 21993342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.